WAM
INDV icon

Weiss Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Weiss Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.9M Buy
+259,129
New +$8.56M 0.13% 134
2025
Q2 		– Sell
-465,048
Closed -$4.43M – 470
2025
Q1 		$4.43M Sell
465,048
-352,924
-43% -$3.71M 0.09% 118
2024
Q4 		$10.2M Buy
+817,972
New +$8.41M 0.19% 117
2024
Q2 		– Sell
-13,620
Closed -$292K – 348
2024
Q1 		$292K Buy
+13,620
New +$256K 0.01% 241

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Asset Management's INDV Position: Q1 2026 in Review

Weiss Asset Management opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 259,129 shares worth $7.9M. The stake represents 0.13% of the portfolio and ranks #134 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in INDV as recently as Q1 2025.

Weiss Asset Management first reported a position in INDV in Q1 2024 and has held it in 4 quarters since. The position peaked at $10.2M in Q4 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Weiss Asset Management held 259,129 shares of Indivior Pharmaceuticals worth $7.9M as of Q1 2026.
  • Indivior Pharmaceuticals was a new Weiss Asset Management position in Q1 2026.
  • Indivior Pharmaceuticals made up 0.13% of Weiss Asset Management's portfolio in Q1 2026, its #134 holding.
  • Weiss Asset Management first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Weiss Asset Management's Indivior Pharmaceuticals position peaked at $10.2M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.